Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.4 (
deaminase
)
5,113
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the present study it is shown that a preparation of highly purified
plasma kallikrein
(specific activity 81 S-2302 U/mg) still contained small amounts of an IgG fraction. Amidase assays of the fresh enzyme with four peptide substrates (S-2302, Bz-Pro-Phe-Arg-pNA, S-2366, S-2222) did not reveal any inhomogeneity, and immunoblot experiments with antibodies against prekallikrein yielded only an 85 kD double band. After a storage period (2 years at -70 degrees C), S-2366 and S-2222
amidase
activities not reflecting the initial
kallikrein
appeared. Immunoblot studies with Fc-specific antibodies against IgG showed a 170 kD band, and immunoblots with a monoclonal antibody against prekallikrein demonstrated that, in addition to the 85 kD band, a band with a mol weight of about 152 kD could also be detected. Immunoblots showed that only 85 kD
kallikrein
was recovered in the eluate from Protein G columns, and
amidase
assays based on S-2302 and Bz-Pro-Phe-Arg-pNA showed a recovery of about 70%. The other part of the
kallikrein
(30%) was removed along with the additional S-2366 and S-2222 activities and the IgG3 fraction present. The theory is advanced that the additional activity reflects a
kallikrein
fraction with a mol weight of about 152 kD, and is present in the fresh enzyme preparation in inactive complex with IgG. Storage of the
kallikrein
preparation led to some weakening of this complex and the appearance of functional activities of the
kallikrein
fraction involved.
...
PMID:Part of purified human plasma kallikrein removed together with a remaining IgG fraction--immunoblot experiments and functional tests. 1200 9
When human plasma is applied to a dermatan sulfate column,
amidase
activity is detected in the bound fraction and complement factor H is cleaved [A. Saito, H. Munakata, Factor H is a dermatan sulfate-binding protein: identification of a dermatan sulfate-mediated protease that cleaves factor H, J. Biochem. 137 (2005) 225-233]. Here, the
amidase
-active fraction was purified by sequential gel filtration and hydroxyapatite chromatography, and the
amidase
-active protein was identified to be
plasma kallikrein
by mass spectrometry. The activation of
plasma kallikrein
was further investigated by Western blotting using plasma deficient in prekallikrein or coagulation factor Xll. The dermatan sulfate column-bound fraction of the prekallikrein- and factor Xll-deficient plasmas did not show any
amidase
activity and factor H remained intact. Addition of
kallikrein
, but not activated factor Xll, to factor H purified from plasma resulted in cleavage of factor H. Thus, dermatan sulfate induces contact activation and activates
kallikrein
-mediated cleavage of FH.
...
PMID:Plasma kallikrein is activated on dermatan sulfate and cleaves factor H. 1841 32
<< Previous
1
2
3
4
5
6